Journal rankings · indicator year 2012
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2012
Immunology and Microbiology journal rankings 2012
113 ranked journals · Field in Life Sciences
Immunology and Microbiology has 113 ranked journals in 2012. Its median journal scores above the world average: OJR 1.07 against 1.00, down 0.02 on 2011. A journal needs OJR 1.55 to reach Q1. The top three are Nature Immunology, Immunity, and The Journal of Experimental Medicine.
Ranks and citation indicators: 2012. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2009–2011, the window the 2012 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Immunology and Microbiology (5)
Up to Life Sciences113 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2011. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2009–2011, the window the 2012 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2009–2011 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2003 to 2012. | Compare |
|---|---|---|---|---|---|---|---|
1Nature ImmunologyNature Portfolio · United States | 6.65Q1 | 18.89 0.95 down from 2011 | 653 | 46% | $12,690 | ||
2ImmunityCell Press · United States | 5.97Q1 | 17.34 1.38 down from 2011 | 635 | 100% | $10,400 | ||
3The Journal of Experimental MedicineRockefeller University Press · United States | 4.56Q1 | 13.56 1.18 up from 2011 | 909 | 94% | — | ||
4Annual Review of ImmunologyAnnual Reviews · United States | 3.66Q1 | 48.13 19.00 down from 2011 | 62 | 37% | — | ||
5Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 3.27Q1 | 8.65 0.31 down from 2011 | 1,567 | 51% | $4,900 | ||
6Seminars in ImmunopathologySpringer Science+Business Media · Germany | 3.20Q1 | 7.90 0.52 up from 2011 | 152 | 51% | $3,790 | ||
7The AAPS JournalSpringer Science+Business Media · United States | 2.65Q1 | 4.56 1.19 down from 2011 | 247 | 97% | $5,090 | ||
8Journal of AutoimmunityElsevier BV · United Kingdom | 2.63Q1 | 7.38 2.11 down from 2011 | 273 | 39% | $5,420 | ||
9Mucosal ImmunologyOAElsevier BV · United States | 2.60Q1 | 6.89 0.36 up from 2011 | 215 | 100% | $4,370 | ||
10Seminars in ImmunologyElsevier BV · United States | 2.41Q1 | 6.22 0.36 down from 2011 | 163 | 55% | $4,370 | ||
11The Journal of ImmunologyAmerican Association of Immunologists · United States | 2.25Q1 | 6.47 0.08 down from 2011 | 5,149 | 27% | $3,500 | ||
12International Journal for ParasitologyElsevier BV · Australia | 2.20Q1 | 4.29 0.44 up from 2011 | 441 | 24% | $2,880 | ||
13Infection and ImmunityOAAmerican Society for Microbiology · United States | 2.12Q1 | 4.77 0.14 up from 2011 | 1,673 | 99% | — | ||
14Nature reviews. ImmunologyNature Portfolio · United Kingdom | 2.10Q1 | 14.72 0.25 down from 2011 | 603 | 18% | — | ||
15International Reviews of ImmunologyTaylor & Francis · United States | 2.08Q1 | 6.69 2.84 up from 2011 | 75 | 20% | — | ||
16Journal of Leukocyte BiologyOxford University Press · United States | 1.94Q1 | 5.06 0.39 down from 2011 | 696 | 44% | $3,800 | ||
17Parasites & VectorsOABioMed Central · United Kingdom | 1.91Q1 | 4.46 1.10 up from 2011 | 425 | 100% | $3,090 | ||
18Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 1.89Q1 | 4.69 0.37 down from 2011 | 170 | 4% | $5,490 | ||
19Journal of Innate ImmunityOAKarger Publishers · Switzerland | 1.89Q1 | 4.86 0.51 up from 2011 | 192 | 92% | $3,590 | ||
20International Journal of InflammationOAHindawi Publishing Corporation · United Kingdom | 1.79Q1 | 3.98 1.48 up from 2011 | 50 | 100% | $1,000 | ||
21Inflammation & Allergy - Drug TargetsBentham Science Publishers · Netherlands | 1.78Q1 | 3.10 1.46 down from 2011 | 120 | 10% | — | ||
22Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.73Q1 | 4.58 0.13 down from 2011 | 429 | 22% | — | ||
23Critical Reviews in ImmunologyBegell House · United States | 1.69Q1 | 4.42 0.17 down from 2011 | 85 | 33% | — | ||
24European Journal of ImmunologyWiley · Germany | 1.65Q1 | 4.92 0.14 down from 2011 | 1,276 | 74% | $4,550 | ||
25BioDrugsAdis, Springer Healthcare · Switzerland | 1.64Q1 | 3.76 0.97 down from 2011 | 132 | 9% | $5,190 | ||
26Genes and ImmunitySpringer Nature · United States | 1.61Q1 | 3.95 0.52 down from 2011 | 270 | 51% | $3,190 | ||
27Parasite ImmunologyWiley · United Kingdom | 1.58Q1 | 2.57 0.28 down from 2011 | 254 | 23% | $4,220 | ||
28Sexually Transmitted InfectionsBMJ · United Kingdom | 1.57Q1 | 2.81 0.48 down from 2011 | 523 | 68% | — | ||
29Ticks and Tick-borne DiseasesOAElsevier BV · Germany | 1.55Q1 | 2.84 1.06 up from 2011 | 89 | 14% | $3,010 | ||
30Clinical ImmunologyElsevier BV · Netherlands | 1.52Q2 | 3.89 0.47 down from 2011 | 549 | 29% | $4,400 | ||
31Clinical and Developmental ImmunologyOAHindawi Publishing Corporation · United Kingdom | 1.51Q2 | 3.68 0.62 up from 2011 | 199 | 100% | $2,100 | ||
32Journal of Interferon & Cytokine ResearchMary Ann Liebert, Inc. · United States | 1.47Q2 | 3.89 0.43 up from 2011 | 311 | 39% | — | ||
33Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.46Q2 | 3.84 0.16 up from 2011 | 345 | 28% | $4,990 | ||
34Zoonoses and Public HealthWiley · Germany | 1.44Q2 | 2.37 0.01 up from 2011 | 251 | 32% | $4,880 | ||
35Sexually Transmitted DiseasesLippincott Williams & Wilkins · United States | 1.44Q2 | 2.95 0.03 down from 2011 | 580 | 34% | — | ||
36International ImmunologyOxford University Press · United Kingdom | 1.43Q2 | 3.27 0.26 down from 2011 | 329 | 27% | $3,530 | ||
37Molecular and Biochemical ParasitologyElsevier BV · Netherlands | 1.41Q2 | 2.75 0.58 down from 2011 | 363 | 39% | $3,460 | ||
38Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.38Q2 | 3.92 0.49 down from 2011 | 686 | 93% | $3,816 | ||
39Vector-Borne and Zoonotic DiseasesMary Ann Liebert, Inc. · United States | 1.38Q2 | 2.59 0.29 up from 2011 | 497 | 39% | — | ||
40Cellular and Molecular ImmunologySpringer Nature · China | 1.36Q2 | 3.83 0.48 up from 2011 | 211 | 100% | $5,190 | ||
41Immunologic ResearchSpringer Science+Business Media · United States | 1.36Q2 | 3.95 1.01 up from 2011 | 161 | 47% | $2,890 | ||
42ImmunologyWiley · United Kingdom | 1.35Q2 | 3.57 0.07 down from 2011 | 568 | 58% | $5,330 | ||
43BMC ImmunologyOABioMed Central · United Kingdom | 1.33Q2 | 3.44no change | 201 | 100% | $3,090 | ||
44Experimental ParasitologyElsevier BV · United States | 1.32Q2 | 2.36 0.10 down from 2011 | 657 | 25% | $3,470 | ||
45Immunity & AgeingOABioMed Central · United Kingdom | 1.29Q2 | 2.94 0.39 down from 2011 | 48 | 100% | $3,190 | ||
46ImmunobiologyOAElsevier BV · Germany | 1.28Q2 | 3.11 0.10 down from 2011 | 410 | 22% | $2,840 | ||
47American Journal of Reproductive ImmunologyWiley · United Kingdom | 1.26Q2 | 3.71 0.25 up from 2011 | 392 | 35% | $4,460 | ||
48Molecular ImmunologyElsevier BV · Netherlands | 1.25Q2 | 3.21 0.06 up from 2011 | 919 | 18% | $3,340 | ||
49Immunology and Cell BiologyWiley · Australia | 1.22Q2 | 3.67 0.61 up from 2011 | 398 | 43% | $3,750 | ||
50Parasitology ResearchSpringer Science+Business Media · Germany | 1.21Q2 | 2.68 0.09 up from 2011 | 1,449 | 12% | $4,590 |
Subfields of Immunology and Microbiology, compared.
Journals
Citations made in 2012. Corpus-wide, 75.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
38 additional Immunology and Microbiology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2009–2011, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2012. Publication window: 2009–2011. How these summaries are calculated
- Ranked journals
- 113
- Window papers (baseline)
- 113,003 +17.5% from indicator year 2009
- Median OJR
- 1.07 -6.7% from indicator year 2009
- Rising journals (2025)
- 12Comparison-group list (12)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2009–2011 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 77 | 81 | 84 | 87 | 84 | 88 | 92 | 96 | 96 | 99 | 100 | 109 | 113 | 118 | 117 | 124 | 126 | 135 | 135 | 131 | 134 | 128 | 131 | 132 | 133 | 130 | |
| Window papers (baseline) | 57,420 | 61,729 | 64,988 | 68,564 | 70,081 | 74,504 | 79,076 | 85,172 | 89,884 | 96,132 | 103,748 | 109,236 | 113,003 | 114,572 | 119,036 | 122,584 | 124,030 | 123,505 | 122,958 | 123,895 | 126,939 | 132,755 | 139,280 | 143,532 | 145,253 | 146,708 | |
| Median OJR | 0.70 | 0.78 | 0.80 | 0.76 | 0.79 | 0.837 | 0.88 | 0.945 | 0.98 | 1.15 | 1.11 | 1.089 | 1.07 | 1.04 | 1.052 | 1.053 | 1.092 | 0.99 | 0.954 | 0.948 | 0.89 | 0.847 | 0.841 | 0.854 | 0.87 | 0.853 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 116 journals |
| Retracted papers per 1,000 | Pooled rate: 1.118 per 1,000 | 102 journals |
| Output growth | Median: -14.5% | 121 journals |
| Open access share | Median: 82.5% | 130 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,340 | 99 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 25.3% | 128 journals |
| Review share | Median: 1.1% | 130 journals |
| Articles-only OJR | Median: 0.85 | 125 journals |
| Uncited share | Median: 25.6% | 130 journals |
| Citation concentration | Median: 42.4% | 130 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.